FDA Issues Warning Letters to Unlicensed E-cigarette Sellers and Retailers

Sep.14.2024
FDA Issues Warning Letters to Unlicensed E-cigarette Sellers and Retailers
FDA issues 11 warning letters to companies for unauthorized e-cigarette products sales at trade shows, emphasizing crackdown on illegal behavior.

According to a report on the official website of the US Food and Drug Administration (FDA) on September 13th, the agency has issued 11 warning letters to multiple manufacturers and retailers for selling or distributing unauthorized e-cigarette products at industry trade shows.

FDA Issues Warning Letters to Unlicensed E-cigarette Sellers and Retailers


The FDA's Center for Tobacco Products (CTP) conducted an investigation after attending a trade show and found that six retailers and manufacturers were suspected of selling or distributing unauthorized e-cigarette products, violating regulations under the Federal Food, Drug, and Cosmetic Act. John Verbeten, Director of CTP's Office of Compliance and Enforcement, emphasized that the FDA will gather leads and conduct investigations through various channels, including trade shows, to crack down on illegal activities.


In addition, the FDA has issued warning letters to five online retailers accusing them of selling unauthorized e-cigarette products popular among teenagers, such as brands like Breeze, Mr. Fog, and Raz. These brands of e-cigarette products have high usage rates among teenagers and are favored for their wide variety of flavors.


Source: FDA official website.


Companies that have received a warning letter must respond within 15 business days, detailing the actions taken to address the violations and prevent future non-compliance. Companies that fail to address the issues in a timely manner may face further action by the FDA, including injunctions, seizures, or civil penalties.


The FDA's actions are part of its ongoing efforts to combat the unauthorized sale of e-cigarette products in the supply chain. Over the past year, the FDA has conducted multiple retailer inspections, exposing numerous cases of unauthorized e-cigarette sales, issuing over 690 warning letters, and imposing more than 140 civil penalties on retailers.


It is worth noting that the percentage of American teenagers using e-cigarettes decreased by nearly 25% between 2023 and 2024, dropping from 2.13 million to 1.63 million. The FDA has authorized 34 types of e-cigarette products and devices that are legally sold in the United States. The public can access further information about legally marketed tobacco products in the FDA's searchable tobacco product database. With increasing global regulations on e-cigarettes, governments around the world are taking unprecedented measures to combat illegal e-cigarette activities. From the seizure of over a thousand untaxed e-cigarettes by German customs, to the sales bans imposed by the Department of Trade and Industry in the Philippines on brands such as Relx, Flare, Team X, and Funky Monkey, these actions not only demonstrate the government's commitment to protecting public health and upholding tax regulations but also reflect the international community's collective efforts in combating illegal e-cigarette trade.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts On-Site at InterTabac: Pouch Companies Predict Shake-Out Among ‘Fly by Nights’
2Firsts On-Site at InterTabac: Pouch Companies Predict Shake-Out Among ‘Fly by Nights’
At the 2025 InterTabac, nicotine pouch exhibitors rose to 110, reflecting rapid market growth. Industry players told 2Firsts that tightening regulations and rising competition will eliminate short-lived brands. Long-term success will depend on quality control, in-house production, and strong supply chains. Measures like flavor bans, nicotine caps, and plain packaging are expected to accelerate consolidation.
Sep.22
Bhutan Implements New Tax Framework to Combat Non-Communicable Diseases and Reduce Alcohol and Tobacco Consumption
Bhutan Implements New Tax Framework to Combat Non-Communicable Diseases and Reduce Alcohol and Tobacco Consumption
New tax framework aimed at reducing alcohol and tobacco consumption to tackle rising non-communicable diseases crisis in Bhutan.
Sep.04 by 2FIRSTS.ai
Relx Technology Q2 2025 Financial Report: Net Revenue Grew by 40.3% Year-over-year to 880 Million Yuan, Net Profit Increased by 35.6%
Relx Technology Q2 2025 Financial Report: Net Revenue Grew by 40.3% Year-over-year to 880 Million Yuan, Net Profit Increased by 35.6%
In the second quarter of 2025, Relx Technology achieved a net revenue of 880 million yuan, representing a year-over-year increase of 40.3% and a quarter-over-quarter increase of 8.9%. The net profit reached 290 million yuan, up by 35.6% year-over-year. The gross profit was 240 million yuan, with a gross margin of 27.5%.
Aug.22 by 2FIRSTS.ai
US FDA releases MRTP renewal application materials for IQOS heated tobacco product and will hold an expert meeting in October
US FDA releases MRTP renewal application materials for IQOS heated tobacco product and will hold an expert meeting in October
New materials related to Philip Morris Products' MRTP renewal application have been submitted to the FDA for review.
Sep.26 by 2FIRSTS.ai
Interview with Vabeen CEO Shuai: Full-Portfolio Push, Compliance-First Strategy to Build Global Competitiveness
Interview with Vabeen CEO Shuai: Full-Portfolio Push, Compliance-First Strategy to Build Global Competitiveness
At InterTabac 2025, Vabeen CEO Shuai told 2Firsts that Vabeen has launched two flagship products—the multi-flavor pod-mod iPlex and the open-system Billow Pro—while showcasing a complete lineup spanning disposables, pod systems, and open systems. In his view, Vabeen treats “compliance-first” as a long-term strategy and sees strict regulation as an opportunity for industry upgrading. Over the next two to three years, Vabeen will continue to focus on three pillars—compliance, user experience, and
Sep.19
The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
In Sept 2025, the US FDA launched a nicotine pouch PMTA pilot to boost review efficiency, streamline processes and uphold strict scientific standards. Based on the "tobacco product health risk continuum" concept, it shortens cycles by focusing on key product factors and enhancing real-time communication with applicants. The FDA also urges child-resistant packaging to tackle kids’ accidental exposure, emphasizes scientific review for new tobacco products, and has approved 20 nicotine pouches so f
Sep.19 by 2FIRSTS.ai